262 related articles for article (PubMed ID: 21557530)
1. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
Zhu TY; Tam LS; Li EK
Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
3. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
Meacock R; Dale N; Harrison MJ
Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs.
Anandarajah AP; Luc M; Ritchlin CT
Lupus; 2017 Jun; 26(7):756-761. PubMed ID: 27831537
[TBL] [Abstract][Full Text] [Related]
6. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
[TBL] [Abstract][Full Text] [Related]
7. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of systemic lupus erythematosus.
Panopalis P; Clarke AE; Yelin E
Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):695-704. PubMed ID: 23218432
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
[TBL] [Abstract][Full Text] [Related]
10. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
Kariburyo F; Xie L; Sah J; Li N; Lofland JH
J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
[No Abstract] [Full Text] [Related]
11. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
12. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
13. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
14. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States.
Drenkard C; Bao G; Dennis G; Kan HJ; Jhingran PM; Molta CT; Lim SS
Arthritis Care Res (Hoboken); 2014 Jun; 66(6):878-87. PubMed ID: 24339382
[TBL] [Abstract][Full Text] [Related]
15. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
Park SY; Joo YB; Shim J; Sung YK; Bae SC
Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
[TBL] [Abstract][Full Text] [Related]
16. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs.
Clarke AE; Esdaile JM; Bloch DA; Lacaille D; Danoff DS; Fries JF
Arthritis Rheum; 1993 Nov; 36(11):1548-59. PubMed ID: 8240431
[TBL] [Abstract][Full Text] [Related]
17. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
Clarke AE; Urowitz MB; Monga N; Hanly JG
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
19. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.
Panopalis P; Yazdany J; Gillis JZ; Julian L; Trupin L; Hersh AO; Criswell LA; Katz P; Yelin E
Arthritis Rheum; 2008 Dec; 59(12):1788-95. PubMed ID: 19035422
[TBL] [Abstract][Full Text] [Related]
20. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
